IRIS
SOLINAS, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.400
EU - Europa 1.499
AS - Asia 889
OC - Oceania 11
AF - Africa 5
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.811
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.384
UA - Ucraina 689
CN - Cina 564
SG - Singapore 289
SE - Svezia 233
DE - Germania 231
IT - Italia 122
FI - Finlandia 106
GB - Regno Unito 65
BE - Belgio 16
CA - Canada 13
AU - Australia 11
IN - India 10
TR - Turchia 9
FR - Francia 8
RU - Federazione Russa 6
IE - Irlanda 4
BR - Brasile 3
ES - Italia 3
LU - Lussemburgo 3
MX - Messico 3
NL - Olanda 3
BG - Bulgaria 2
DZ - Algeria 2
EU - Europa 2
ID - Indonesia 2
JP - Giappone 2
KR - Corea 2
PK - Pakistan 2
RO - Romania 2
SD - Sudan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
NO - Norvegia 1
NP - Nepal 1
TH - Thailandia 1
TN - Tunisia 1
Totale 4.811
Salva come PNG Salva come JPEG
Città #
Chandler 630
Jacksonville 419
Singapore 236
Princeton 214
Nanjing 181
Dearborn 157
Wilmington 105
Ann Arbor 67
Nanchang 67
Boardman 62
Beijing 54
Hebei 40
Shenyang 34
Woodbridge 34
Changsha 31
Andover 29
Jiaxing 26
Sassari 26
Tianjin 25
Santa Clara 22
Hangzhou 19
Kunming 17
Norwalk 17
Brussels 16
Jinan 15
Ashburn 14
Los Angeles 11
Dallas 9
Toronto 9
Marrùbiu 8
Auburn Hills 7
Ningbo 7
Lanzhou 6
Olbia 6
Zhengzhou 6
Falls Church 5
Munich 5
San Francisco 5
Settimo San Pietro 5
Dublin 4
Frankfurt am Main 4
Haikou 4
Hefei 4
Houston 4
Amsterdam 3
Baotou 3
Guangzhou 3
Helsinki 3
Madrid 3
Melbourne 3
New York 3
Padova 3
Rome 3
Saint Paul 3
Seattle 3
Shanghai 3
Turin 3
Algiers 2
Augusta 2
Canberra 2
Changchun 2
Chicago 2
Edinburgh 2
Forest City 2
Fuzhou 2
Hyderabad 2
Izmir 2
Lahore 2
London 2
Luxembourg 2
Manchester 2
Ottawa 2
Raleigh 2
Redmond 2
Saint Petersburg 2
Seoul 2
Sofia 2
São Paulo 2
Taiyuan 2
Taizhou 2
Tokyo 2
Baltimore 1
Banbury 1
Bandar Seri Begawan 1
Bangalore 1
Bangkok 1
Brisbane 1
Carbonia 1
Catanduva 1
Catania 1
Centro 1
Chengdu 1
Cupertino 1
Dhaka 1
Dubai 1
Foggia 1
Gatineau 1
Haifa 1
Horia 1
Huntington 1
Totale 2.772
Salva come PNG Salva come JPEG
Nome #
Skin Reaction in Antiviral therapy for Chronic Hepatitis C: A role for Polyethylene Glycol Interferon? 80
The role of pre-coreHBV mutants on the long-term outcome of chronic HBV hepatitis 72
Cognitive dysfunction and hepatitis C virus infection 70
Chronic liver disease, alcohol consumption and HBsAg antigen in Italy: a multi-regional control study 69
ARFI (acoustic radiation force impulse imaging) elastography in the liver fibrosis evaluation in HCV correlated chronic liver disease 68
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients 67
Acute hepatitis with bridging necrosis due to hydralazine intake. Report of a case 67
Lichen planus associated with anti-liver-kidney mocrosome-positive chronic active hepatitis and hyperthyroidism 65
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells 63
CHANGES OF SERUM 2-5 OLIGOADENYLATE SYNTHETASE DURING INTERFERON TREATMENT OF CHRONIC HEPATITIS C 62
Course of patients coinfected with HIV and hepatotropic viruses 62
Lessons from rare tumors: Hepatic lymphoepithelioma-like carcinomas 60
ASSESSMENT OF VARICEAL PRESSURE WITH AN ENDOSCOPIC BALLOOON: EFFECTS OF PHARMACOLOGICAL THERAPY 58
Alanine amino-transferase, Alpha-fetoprotein, hepatocellular necrosis and regeneration in chronic liver disease 58
A 15 year old girl with fever, jaundice, haemolysis, and sudden clinical deterioration 57
Thyrotropin (TSH) and prolactin (PRL) responses to thyrotropin releasing hormone (TRH) in chronic alcoholism (CA) and in liver cirrhosis (LC) 57
Histologic changes in liver biopsy specimens produced by recombinant interferon alpha-2b therapy for chronic non-A, non-B hepatitis. A randomized controlled trial 56
The long lasting course of chronic hepatitis C infected patients treated with interferon alfa-2b 56
Toxic epidermal necrolysis in a patient affected by mixed essential cryoglobulinemia 55
Portohepatic gradient and portal hemodynamics in patients with cirrhosis due to hepatitis C virus infection 55
Lichen planus, chronic liver disease and immunologic involvement 53
Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study 53
Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP) 53
Autoantibodies and response to alpha interferon in patients with chronic viral hepatitis 52
Impaired thyrotropin (TSH) response to thyrotropin releasing hormone (TRH) in hepatic encephalopathy 52
Twenty-four novel mutations in Wilson Disease of predomintaly Italian origin 51
Growth hormone (GH) secretion in hepatic encephalopathy 51
Autoimmunity in interferon treated patients with viral chronic liver disease of different etiologies 50
High resolution-magic angle spinning (HR-MAS)-NMR based metabolomic fingerprints of early and recurrent hepatocellular carcinoma 50
Antibody to Hepatitis B Surface Antigen in chronic liver disease 50
Espressione immunomorfologica e quadri sierologici dell'epatite da virus B 49
The problem of cancer diagnosis in thyroid nodules: a study in an endemic area for goiter in North Sardinia 49
Alterazioni degli indici di funzionalità tiroidea nelle epatopatie croniche. 49
Alpha-fetoprotein and Hepatitis B Virus infection in chronic liver disease 48
Identification of Mycobacterium avium subsp paratuberculosis in biopsy specimens from patients with Crohn\'s disease identified by in situ hybridization 48
Interferon alpha therapy in sicilian and sardinan polytransfused thalassemic patients with chronic hepatitis C 48
Changes of serum 2-5 olygoadenylate synthetase during interferon treatmnet of chronic hepatitis C 48
Porto-hepatic gradient and portal hemodynamics in patients with cirrhosis due to hepatitits C virus infection 48
Thymic hormones in the treatment of chronic HBV infection 48
tHE LONG-TERM VARICEAL PRESSURE RESPONSE TO NADOLOL ALONE AND NADOLOL PLUS ISOSORBIDE MONONITRATE 47
Systemic lupus erythematosus in a patient with chronic hepatitis C 47
Changes of serum 2-5- olygoadenilate synthetase during interferon therapy in patients with chronic HCV hepatitis 47
Programmed death ligand 1 expression in hepatocellular carcinoma: A prognostic marker and therapeutic target for liver cancer? 47
MOLECULAR PATHOLOGY AND HAPLOTYPE ANALYSIS OF WILSON DISEASE IN MEDITERRANEAN POPULATIONS 47
Enfermedad de Erdheim-Chester: reporte de 2 casos 46
Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis 46
us-GUIDED DIRECT TRANS-HEPATIC MEASUREMENT OF THE VENOUS PORTAL GRADIENT: A NEW APPROACH TO EVALUATE PORTAL HYPERTENSION 46
The tumour microenvironment and immune milieu of cholangiocarcinoma 46
SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model 46
Effect of different doses (1,000,000 AND 3,000,000 units ) od interferon alfa on the ALT levels of nonAnonB patients 46
A randomized controlled trial of interferon alpha-2b as therapy for chronic non-A, non-B hepatitis 45
T lymphocyte subsets in parenteral and non-parenteral heroin abusers in Britain 45
M. paratuberculosis may cause Crohn’s disease 44
Livelli sierici delle frazioni C3 e C4 del complemento in corso di epatopatia 44
Pituitary secretion in hepatic encephalopathy 44
Epatite cronica in pazienti con coinfezione multipla HIV-Virus epatotropi 44
Hepatitis D Virus infection in parenteral drug abusers 44
PROLONGED TREATMENT (2YEARS) WITH DIFFERENT DOSES (3 VS 6 MU) OF INTERFERON ALFA2B FOR CHRONIC HEPATITIS C 44
Longitudinal study of anti-HBe and DNA polymerase positive patients with chronic liver disease 44
The predictive value of free thyroid hormones in patients with liver cirrhosis 43
High resolution-magic angle spinning (HR-MAS) NMR-based metabolomic fingerprinting of early and recurrent hepatocellular carcinoma 43
Circulating immune complexes during acute viral hepatitis type B: an attempt to detect HBsAg as their antigenic component by means of direct immunofluorescence on Raji cells 43
Alteration in thyrotropin (TSH), Prolactin (PRL) and Growth Hormone (GH) secretions in chronic alcoholism and in liver cirrhosis. 43
Aspetti della diagnostica delle infezioni croniche da virus dell'epatite B 43
PRE-CORE MUTANTS AND RESPONSIVENESS TO INTERFERON IN CHRONIC HEPATITIS B 43
Free thyroid hormone concentration in chronic alcoholes with liver steatosis. M. Langer, S. Rassu, P.P. 43
Marcatori del virus dell'epatite B, stato della replicazione virale condizioni cliniche associate 42
Immune complexes and complement system in HBsAg positive liver diseases 42
Patterns of response during therapy with interferon and outcome of retreatment with interferon plus ribavirin 42
Growth hormone secretion in chrnic liver disease 42
HBsAg carrier and liver disease 42
Systemic amyloidosis rapidly progressing to liver failure and hepato-renal syndrome. Report of a case 41
Il trattamento con levamisolo in corso di epatite cronica attiva 41
Polymerase chain reaction assay for detection of Hepatitis B Virus DNA in the serum of HBsAg/antiHBe positive subjects 41
Patterns of respnse during therapy with interferon and outcome of of retreatment with interferon plus ribavirin 40
CARRIER DETECTION AND EARLY DIAGNOSIS OF WILSON'S DISEASE BY RESTRICTION FRAGMENT LENGTH POLYMORPHISM ANALYSIS 39
Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. AISF Group for the study of liver transplantation 39
Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary centres in Europe 39
TSH secretion in patients with hepatic encephalopathy 39
Alanic transferase, Alphafetoprotein, hepatocellular necrosis and regeneration in chronic liver disease. 39
Aspetti di terapia delle epatiti croniche da virus B e non-A,non-B 39
Late diagnosis of Wilson's Disease: a single center experience over two decades 39
Thyrotropin (TSH) and prolactin (PRL) responses to thyrotropin-releasing hormone (TRH) in chronic alcoholism (CA) and in liver cirrhosis (LC) 39
Recurrent Hepatitis Delta Virus infection after liver transplantation 38
Characterization of Hepatitis B Virus Core region DNA in circulating Dane particles using direct sequencing of single stranded template generated by asymmetric polymerase chain reaction 38
Sex steroids and sex hormone binding globulin in males with chronic alcoholism and liver cirrhosis 37
Occurrence of hepatocellular carcinoma and decompensation in Western patients with cirrhosis type B 35
Receptors for polymerized human serum albumin 35
Reazioni cutanee da farmaco: manifestazione eczema-like in corso di terapia antivirale per epatite da virus C 33
Hepatic hemodynamics and liver function: comparison of a six month course of nadolol and octreotide 33
Follow-up study of alpha-fetoprotein in chronic liver disease. Its role in the detection of primary hepatocellular carcinoma. 32
Correlazione tra aspetti istologici e valori sierici di alfafetoproteina in epatopatie croniche HBV positive. 31
Correlazione tra aspetti istologici e valori serici di AFP in epatopatie croniche HBV positive 31
Interferon therapy for chronic hepatitis C 31
The canine copper toxicosis gene MURR1 is not implicated in the pathogenesis of Wilson Disease 31
Sequence analysis of Hepatitis B Virus mutants isolated in Sardinia i HBsAg negative chronic hepatitis 31
Imaging e valutazione emodinamica nella diagnostica epatologica. Emodinamica epatica invasiva 30
Effectiveness of interferon alpha on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C 30
Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon alpha 2b 30
Serum Markers of HBV infection and alphafetorprotein in chronic non malignant liver disease. 29
Totale 4.657
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.327
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020724 0 0 0 0 103 137 214 7 117 29 112 5
2020/2021893 106 0 161 4 107 56 119 0 145 136 33 26
2021/2022503 93 1 3 2 3 5 37 34 52 14 50 209
2022/20231.182 113 58 15 183 155 206 0 162 214 12 34 30
2023/2024180 66 21 5 10 23 1 0 9 0 0 9 36
2024/2025361 24 15 175 43 104 0 0 0 0 0 0 0
Totale 4.834